1. Home
  2. LC vs IMCR Comparison

LC vs IMCR Comparison

Compare LC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingClub Corporation

LC

LendingClub Corporation

HOLD

Current Price

$19.96

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LC
IMCR
Founded
2006
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
LC
IMCR
Price
$19.96
$36.52
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$22.67
$67.00
AVG Volume (30 Days)
1.5M
333.0K
Earning Date
01-27-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
93.62
N/A
EPS
0.89
N/A
Revenue
$1,296,102,000.00
$379,590,000.00
Revenue This Year
N/A
$32.31
Revenue Next Year
$16.10
$10.50
P/E Ratio
$22.32
N/A
Revenue Growth
16.98
28.11
52 Week Low
$7.90
$23.15
52 Week High
$20.94
$40.72

Technical Indicators

Market Signals
Indicator
LC
IMCR
Relative Strength Index (RSI) 64.66 49.05
Support Level $18.98 $35.35
Resistance Level $20.94 $40.71
Average True Range (ATR) 0.68 1.82
MACD 0.23 -0.45
Stochastic Oscillator 78.92 22.55

Price Performance

Historical Comparison
LC
IMCR

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: